Subsequently, GSEA was applied between the high- and low-MCTS1 expression groups, and more immune-related biological processes were found to be significantly enriched in the low MCTS1 expression group, suggesting that the high expression of MCTS1 conferred a decreased immune phenotype in breast cancer (Figures 5A–D). This evidence concerns the gene MCTS1 and breast carcinoma.